Last $57.31 USD
Change Today +1.11 / 1.98%
Volume 12.9M
MRK On Other Exchanges
Symbol
Exchange
New York
Mexico
EN Paris
Sao Paulo
Frankfurt
As of 8:04 PM 10/30/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Adel A. F. Mahmoud M.D., Ph.D.

Former Chief Medical Advisor of Vaccines & Infectious Diseases, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 103 board members in 7 different organizations across 7 different industries.

See Board Relationships
72--

Background*

Prof. Adel A. F. Mahmoud, M.D., Ph.D., has been a Professor at Princeton University in the Department of Molecular Biology and the Woodrow Wilson School of Public and International Affairs since 2007. Dr. Mahmoud served as the Chief Medical Advisor, Vaccines and Infectious Diseases of Merck & Co., Inc. since September 1, 2005 until 2006. He served as the President of Merck Vaccines, a subsidiary of Merck & Co. Inc. from May 1999 to 2005. Prior to November 1998, Dr. Mahmoud ...

Read Full Background

Corporate Headquarters*

One Merck Drive
Whitehouse Station, New Jersey 08889

United States

Phone: 908-423-1000
Fax: --

Board Members Memberships*

2006-2014
Former Independent Director, Member of Science, Innovation & Technology Committee and Member of Corporate Governance & Nominating Committee
2011-2013
Former Director and Member of Nominating & Corporate Governance Committee
2012-Present
Director, Member of Nomination & Corporate Governance Committee and Member of Compensation Committee
2012-Present
Director
2012-Present
Director
2013-Present
Chairman

Education*

PhD 1971
London School Of Hygiene And Tropical Medicine
Unknown/Other Education
Faculty of Medicine, University of Ain Shams
MD 1963
Cairo University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:US $57.31 USD +1.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$436.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
--
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.